Existing therapies applied to new use in broader spectrum of cancer care

ORLANDO - Drugs approved for treatment of specific maladies sometimes show unexpected benefits. Researchers at the 95th annual meeting of the American Association for Cancer Research demonstrated highlighted how some drugs may one day offer previously unforeseen benefits for patients.

The research was presented here today at the 95th Annual Meeting of the American Association for Cancer Research. Inhibition of experimental colon cancer metastasis by the GABA-receptor agonist Nembutal: Abstract No. 5513

A drug that acts as a "downer" on the central nervous system also works to suppress metastasis in an experimental model of colon cancer, according to researchers from M.D. Anderson Cancer Center in Houston, Tex.

The barbiturate Nembutal, or pentobarbital, is known to have similar effects in the brain as gamma-aminobutyric acid (GABA), a neurotransmitter-inhibiting amino acid. Nembutal acts in the manner of a GABA receptor agonist. GABA acts through cell surface receptors, and GABA receptor membrane proteins are present not only in the brain, but on colon and ovarian cancer cells as well.

Premal Thaker, M.D., and colleagues, tested whether Nembutal activated GABA receptors on the cancer cells both in culture and in vivo using a mouse model for colon cancer. After confirming the presence of GABA receptors in the colon cancer cell lines, the researchers documented a marked reduction in cellular cAMP concentrations in colon cancer cell lines treated with Nembutal.

In animal models, nude mice were injected in the cecum or spleen with KM12SM, a GABA receptor positive colon cancer cell line. Nearly half as many mice treated with Nembutal (4 of 10) developed primary tumors after injection in the spleen as the non-Nembutal treated mice (8 of 10). When the cells were injected into the

Contact: Aimee Frank
American Association for Cancer Research

Page: 1 2 3 4 5

Related medicine news :

1. Existing anti-inflammatory drug could help children suffering from an inherited bone disease
2. Study Shows Calcitonin-Salmon Nasal Spray Helps Prevent New Spinal Fractures In Women With Existing Osteoporosis
3. UCSD-Utah team develops mouse model to test therapies for macular degeneration
4. Penn joins major NCI research initiative to advance breast cancer therapies
5. Third of European cancer patients use complementary and alternative therapies
6. Study confirms ICDs more effective in preventing sudden cardiac death than medical therapies
7. Multiple therapies curb declining ability to learn with age
8. Complementary and alternative therapies and conventional medical therapies
9. Genetically targeted therapies create opportunities to do business in new ways
10. Certain high blood pressure combination therapies elevate risk for death from cardiovascular disease
11. Pediatricians wary about recommending complementary therapies

Post Your Comments:

(Date:5/26/2020)... ... May 26, 2020 , ... ... RevSpring solutions—Talksoft® patient messaging and IVR Advantage™--for Loyale customers. Talksoft pre-service messaging ... and precise texts, IVR reminders and email messages tailored to each stage ...
(Date:5/26/2020)... NEW YORK (PRWEB) , ... May 26, 2020 ... ... due to the coronavirus pandemic, medical centers across the United States are joining ... front-line health care workers who have worked tirelessly to save lives. #FitForTheFrontLine is ...
(Date:5/21/2020)... ... May 21, 2020 , ... In response to the Coronavirus ... that allows users to open swing-style doors without using their hands or fingertips. ... pull the door open using their forearm, wrist or elbow when entering or exiting ...
(Date:5/21/2020)... ... 2020 , ... Having the cushion of an already established ... gained ground with the inherited reputation of quality, innovation, and professionalism. The VITA ... effective way for the ingredients to become immediately available to the cells. This ...
(Date:5/21/2020)... ... May 21, 2020 , ... In ... will be lifted on May 28th and all businesses will be required to ... returning back to work. , As an essential business, AmeriCare Medical began this ...
Breaking Medicine News(10 mins):
(Date:5/30/2020)... , ... May 29, 2020 , ... ... to funding transformational early-phase cancer research, is excited to announce the launch of ... to advance cancer science and care. , The COVID-19 pandemic has resulted ...
(Date:5/28/2020)... , ... May 28, 2020 , ... May is Talking ... the parents and champions who care about them. The focus of Power to Decide’s ... the lives of young people. Power to Decide’s Mackenzie Piper, MPH, CHES, provides five ...
(Date:5/27/2020)... ... May 27, 2020 , ... ... Jeffrey Taub , a biomedical engineer with more than 25 years of experience ... joined the firm as an Expert Consultant. His expertise includes quality assurance, including ...
Breaking Medicine Technology:
Cached News: